To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
TPG to pay $1.3bn for Canadian drug firm
Axcan Pharma has agreed to be taken private by TPG in a transaction valued at $1.3 billion. It’s the firm’s third healthcare acquisition this year.
